ANGIOSCULPT PTCA SCORING BALLOON CATHETER (RX) 2200-3015

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,health report with the FDA on 2020-03-28 for ANGIOSCULPT PTCA SCORING BALLOON CATHETER (RX) 2200-3015 manufactured by Spectranetics.

Event Text Entries

[185505090] The patient's dob or age at time of event, and weight are unknown. This information was not available from the facility. During withdrawal, the angiosculpt device separated in two pieces. Additional intervention was performed for removal with no success, thus the distal portion of the device was retained in the patient. The angiogram was received on 03/13/2020. Review of the angiogram revealed an implantable cardioverter-defibrillator (icd) in the heart (possibly a biventricular icd). The coronary angiogram presented a moderately calcified lad with a severe mid lesion, non-dominant left circumflex (lcx), and diffuse calcific disease of the dominant right coronary artery (rca). There was no ventriculography? (lv gram) done. The mid lad lesion was predilated with a workhorse balloon, which showed a significant waist in the balloon during inflation, with eventual rupture of the balloon. After the predilatation, there was a non-flow limited dissection in the proximal part of the lesion, which did not inhibit passage of the angiosculpt balloon. It appears that the angiosculpt was inflated several times within the original lesion. Finally it appears that the angiosculpt was stuck in the proximal lad (proximal to the lesion). The last image had an unknown radio-opaque density in the guiding catheter (possibly a snare). Patient information regarding relevant tests/laboratory data is unknown. This information was not available from the facility. The angiosculpt device was returned taped to an unused angiosculpt device. The complaint device was returned without the entire distal assembly (distal tip, distal bond, balloon, scoring element, marker bands, intermediate bond, inner member, transition tubing, rx port (support tubing), support wire, proximal bond, distal shaft, and part of the intermediate shaft). The distal assembly portion of the device that was not returned is approximately 29 cm (11 inches). The returned portion includes a part of intermediate shaft, hypotube, core wire, strain relief, and luer. The hypotube was bent likely due to packaging for device return. The device separated approximately 108 cm from the breaking point (core wire) to the distal end of the strain relief. The overall catheter working length spec is 137 cm +/- 3 cm. During withdrawal, it is probable that the degree of force applied by the user may have caused or contributed to the device separation. Per the ifu, retained device component is listed as a possible adverse effect of the procedure.
Patient Sequence No: 1, Text Type: N, H10


[185505091] The patient was admitted with sleep apnea, pneumonia, made enzymes, and diagnosed with severe mid lad disease. The physician predilated the lesion with an apex balloon. To make it "look nicer," an angiosculpt device was advanced with no problem maneuvering the balloon down to the mid lad. The balloon was inflated multiple times below rbp (18 atm), with no issues. During withdrawal, the balloon got stuck in the proximal lad and not in the original lesion. No stent was present in the proximal lad with not much calcium observed. The physician moved the guiding catheter up to the balloon, tugged it 2-3 times with slight resistance, along with several inflation, but the device separated in 2 pieces and retained in the patient. The patient went into surgery and got a bypass to the lad. Due to the sleep apnea and pneumonia, the patient got tracheal post-op. Upon removal of the proximal shaft, the physician compared it to an unused angiosculpt device to measure the length of the retained portion. The physician believed the device separated at the distal transition point, and approximately 6-7 inches was retained in the body.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3005462046-2020-00005
MDR Report Key9894900
Report SourceCOMPANY REPRESENTATIVE,HEALTH
Date Received2020-03-28
Date of Report2020-03-03
Date of Event2020-02-28
Report Date2005-01-01
Date Reported to FDA2005-01-01
Date Reported to Mfgr2005-01-10
Date Mfgr Received2020-03-03
Date Added to Maude2020-03-28
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. ANA TAN
Manufacturer Street5055 BRANDIN COURT
Manufacturer CityFREMONT CA 94538
Manufacturer CountryUS
Manufacturer Postal94538
Manufacturer Phone510933-798
Manufacturer G1SPECTRANETICS
Manufacturer Street5055 BRANDIN COURT
Manufacturer CityFREMONT CA 94538
Manufacturer CountryUS
Manufacturer Postal Code94538
Single Use0
Previous Use Code0
Event Type3
Type of Report3

Device Sequence Number: 1

Brand NameANGIOSCULPT PTCA SCORING BALLOON CATHETER (RX)
Generic NameANGIOSCULPT RX PTCA
Product CodeNWX
Date Received2020-03-28
Returned To Mfg2020-03-13
Model Number2200-3015
Catalog Number2200-3015
Lot NumberG19110022
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device Sequence No1
Device Event Key0
ManufacturerSPECTRANETICS
Manufacturer Address5055 BRANDIN COURT FREMONT CA 94538 US 94538

Device Sequence Number: 101

Product Code---
Date Received2020-03-28
Device Sequence No101
Device Event Key0


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Required No Informationntervention 2020-03-28

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.